NASH & Fibrosis Clinical Development Liaison - Phase 3

Scorpion Therapeutics is seeking a clinical development professional to support the advancement of MASH therapeutics, including Rezdiffra (resmetirom), focused on Phase 3 outcomes trials for fibrosis and cirrhosis. You will work cross-functionally with clinical, regulatory, and biometrics teams to plan trials, prepare regulatory submissions, and guide phase progression. An advanced degree in a relevant field and experience in metabolic liver disease are highly valued. #J-18808-Ljbffr Scorpion Therapeutics